Biotechnology, Healthcare, and Research by Vertex Pharmaceuticals
496.77
2.8800
0.58 %
Real-time price
11:19
USD
Daily range
489.59
497.30
497.30
Weekly range
469.93
503.64
503.64
Rockefeller Capital stake increase propels Vertex Pharmaceuticals stock higher by 3.42%
Vertex Pharmaceuticals Incorporated (VRTX) stock is trading at $467.2, up 3.42% on the day and sitting above its key moving averages. The stock is showing notable ...
Why is Vertex Pharmaceuticals stock up today?
Vertex Pharmaceuticals Incorporated (VRTX) rose 2.74% after strong institutional activity, as Rockefeller Capital Management significantly increased its stake in the company. The advance is ...
Vertex Pharmaceuticals stock remains under pressure after regulatory submission update and continued weekly decline
Vertex Pharmaceuticals presented data on its gene-edited therapy for people with sickle cell disease or transfusion-dependent beta thalassemia at the European Hematology Association Congress.The ...
Vertex Pharmaceuticals stock consolidates near highs after North Macedonia reimbursement agreement extension
Vertex Pharmaceuticals has extended its reimbursement agreement with the National Health Insurance Fund in North Macedonia.Since May 20, 2026, eligible people living with cystic fibrosis age 2 ...
Sustained momentum drives Vertex Pharmaceuticals stock higher despite signs of overbought conditions
Vertex Pharmaceuticals (VRTX) stock is trading at $446.58, up 4.26% on the day. The current price sits above its key moving averages, reflecting continued upward ...
Why is Vertex Pharmaceuticals stock down today?
Vertex Pharmaceuticals Incorporated (VRTX) closed at $427.91, reflecting a decline of $10.62 or 2.42% for the day. The stock remains below its 20-day, 50-day, and 200-day moving averages, ...
Vertex Pharmaceuticals shares dip amid rising selling pressure
Vertex Pharmaceuticals Incorporated (VRTX) currently trades at $436.80, down 2.39% for the day after opening with a downside gap. The price remains above both the 20-day and 200-day moving ...
Buying pressure lifts Vertex Pharmaceuticals stock higher in today's trading
Vertex Pharmaceuticals Incorporated (VRTX) is trading at $447.15, up 2.27% for the day. The stock is positioned above the 20-day ($433.88), 50-day ($439.03), and 200-day ($435.40) simple moving ...
$440–$445 resistance stalls Vertex Pharmaceuticals stock advance
Vertex Pharmaceuticals (VRTX) stock is trading at $436.11, marking a daily gain of 0.35%. The current price is positioned above its short-term moving average while ...
Positive phase 3 IgA nephropathy data sees Vertex Pharmaceuticals stock slip despite promising update
Vertex Pharmaceuticals announced positive topline results from the interim analysis of the RAINIER Phase 3 study of its investigational therapy for IgA nephropathy.The company shared the update in ...
